Clinical Trials in San Francisco

Showing 4901-4920 of 12,991 trials

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084

The purpose of this study is to determine the proportion of subjects with HIV-1 RNA \< 50 c/mL at Week 48 in patients who failed their first line therapy containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) or an integrase inhibitor

HIV

Bristol-Myers SquibbStarted Jun 2012

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +11 more locations

TERMINATEDPhase 1/2< 1 mile

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

NCT05363605

This first-in-human study evaluates safety, tolerability and distribution of \[225Ac\] FPI-1966, \[111In\]-FPI-1967, and vofatamab in patients with FGFR3-expressing solid tumors.

Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more

Fusion Pharmaceuticals Inc.6 participantsStarted Apr 2022

Duarte, California, United States • San Francisco, California, United States • Iowa City, Iowa, United States +3 more locations

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Find Trials by Condition in San Francisco

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

Intranasal Oxytocin for Frontotemporal Dementia

Bundled Hyperpolypharmacy Deprescribing

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/

Intralesional Injections of Triamcinolone for Acne Vulgaris

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

The Canadian/US Integrative Oncology Study

iCanCope With Sickle Cell Pain

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant